DocDollars

Genentech USA, Inc.

CA · United States · Reporting entity ID 100000000226

Total reported 2019–2025
$71.1M
#132 of 2,960 reporting companies — 0.1% of all reported industry payments
$71.1M in general payments across 447,400 records.

How it breaks down

General payments $71,086,266

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Genentech USA, Inc. reported $71.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #132 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 447,400 general payment records were filed.

Common questions about Genentech USA, Inc.

How much has Genentech USA, Inc. paid US doctors?

Genentech USA, Inc. reported $71,086,266 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $71,086,266 in general payments.

How does Genentech USA, Inc. rank among drug and device companies?

It ranks #132 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Genentech USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.